TransCode Therapeutics Inc.
RNAZ | NASDAQ
$1.76
+$0.11 (+6.67%)
At close: Sep 21, 2026, 4:00 PM ET
$1.84
+$0.08 (+4.55%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 23.94K | n/a | 4.78K | n/a | n/a | n/a | 127.52K | n/a | n/a | 140.17K | 138.78K | 137.59K | 100.2K | 29.51K | 24.8K | 22.7K | 21.6K | 28.99K | 7.54K | 4.69K | 1.26K |
Gross Profit | n/a | -23.94K | n/a | -4.78K | n/a | n/a | n/a | -127.52K | n/a | n/a | -140.17K | -138.78K | -137.59K | -100.2K | -29.51K | -24.8K | -22.7K | -21.6K | -28.99K | -7.54K | -4.69K | -1.26K |
Operating Income | n/a | -7.33M | -16.03M | -4.56M | -4.22M | -3.17M | -5.09M | -2.17M | -5.11M | -3.29M | -4.06M | -5.33M | -5.13M | -4.9M | -5.53M | -4.95M | -4.71M | -3.48M | -2.99M | -2.36M | -355.53K | -449.47K |
Interest Income | 52.17M | 91.89K | 78.76K | 147 | 148 | 146 | 159 | 179 | 178 | 168 | 137 | 131 | 246 | 4.77K | 9.64K | 9K | 1.33K | 442 | 510 | 141 | 1 | 12 |
Pretax Income | -6.75B | -17.55M | -13.22M | -4.86M | -4.28M | -12.09M | -5.92M | -2.32M | -5.19M | -3.33M | -4.09M | -5.3M | -4.34M | -4.82M | -5.13M | -4.29M | -4.67M | -3.47M | -2.8M | -2.33M | 2.77M | -4.49M |
Net Income | -6.87B | -17.79M | -13.44M | -4.86M | -4.28M | -12.09M | -5.92M | -2.32M | -5.19M | -3.33M | -4.09M | -5.3M | -4.34M | -4.82M | -5.13M | -4.29M | -4.67M | -3.47M | -2.8M | -2.33M | 2.77M | -4.49M |
Selling & General & Admin | 2.54B | 2.22B | 1.76M | 1.4M | 1.66M | 951.65K | 1.45M | 826.54K | 2.03M | 1.53M | 555.24K | 1.85M | 2.03M | 2.21M | 2.84M | 1.91M | 2.06M | 1.57M | 1.67M | 1.36M | 139.08K | 185.71K |
Research & Development | 3.69B | 5.11B | 5.48M | 3.16M | 2.57M | 2.22M | 3.64M | 1.21M | 3.08M | 1.76M | 3.36M | 3.34M | 2.97M | 2.59M | 2.66M | 3.02M | 2.62M | 1.88M | 1.29M | 992.95K | 211.75K | 263.76K |
Other Expenses | 559.46M | -7.32B | 8.79M | n/a | n/a | 0 | n/a | n/a | 0 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 6.79B | 7.3M | 16.03M | 4.56M | 4.22M | 3.17M | 5.09M | 2.04M | 5.11M | 3.29M | 3.92M | 5.19M | 4.99M | 4.8M | 5.5M | 4.93M | 4.68M | 3.46M | 2.96M | 2.35M | 350.84K | 449.47K |
Interest Expense | n/a | n/a | 542 | 5.96K | n/a | 114 | 1.83K | 10.79K | 4.48K | 9.71K | 55.9K | 17.28K | 7.84K | 13.43K | n/a | n/a | n/a | n/a | n/a | 333 | 41.97K | 52.77K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 7.33M | 16.03M | 4.56M | 4.22M | 3.17M | 5.09M | 2.17M | 5.11M | 3.29M | 4.06M | 5.33M | 5.13M | 4.9M | 5.53M | 4.95M | 4.71M | 3.48M | 2.99M | 2.36M | 355.53K | 449.47K |
Income Tax Expense | -300K | 231.31K | 226.07K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 957.19K | 916.97K | 916.97K | 833.68K | 833.65K | 172.26K | 356.12K | 356.12K | 213.67K | 213.67K | 213.67K | 109.41K | 30.49K | 30.49K | 30.49K | 16.22K | 16.22K | 16.22K | 16.22K | 14.41K | 14.96K | 14.95K |
Shares Outstanding (Diluted) | 957.19K | 916.97K | 916.97K | 833.68K | 833.65K | 172.26K | 356.12K | 356.12K | 213.67K | 213.67K | 213.67K | 109.41K | 30.49K | 30.49K | 30.49K | 16.22K | 16.22K | 16.22K | 16.22K | 14.41K | 14.96K | 14.95K |
EPS (Basic) | -7.17K | -21.28 | -16.42 | -5.82 | -5.13 | -70.28 | -16.61 | -6.52 | -24.42 | -21.45 | -761.16 | -48.44 | -142.38 | -259.07 | -37.83K | -264.40 | -288 | -216 | -18.4K | -160 | 185.25 | -300.10 |
EPS (Diluted) | -7.17K | -21.28 | -16.42 | -5.82 | -5.13 | -70.28 | -16.61 | -6.52 | -24.42 | -21.45 | -761.16 | -48.44 | -142.38 | -259.07 | -37.83K | -264.40 | -288 | -216 | -18.26K | -160 | 185.25 | -300.10 |
EBITDA | n/a | -17.53M | -13.17M | -4.85M | -4.26M | -12.03M | -5.79M | -2.18M | -5.04M | -3.18M | -3.89M | -5.16M | -4.2M | -4.72M | -5.1M | -4.26M | -4.65M | -3.45M | -2.77M | -2.32M | 2.82M | -4.43M |
EBIT | n/a | -17.55M | -13.22M | -4.85M | -4.28M | -12.09M | -5.91M | -2.31M | -5.19M | -3.32M | -4.03M | -5.3M | -4.34M | -4.82M | -5.13M | -4.29M | -4.67M | -3.47M | -2.8M | -2.33M | 2.81M | -4.43M |
Depreciation & Amortization | n/a | 23.94K | 44.78K | 4.78K | 13.44K | 51.17K | 122.86K | 127.52K | 142.83K | 141.65K | 140.17K | 138.78K | 137.59K | 100.2K | 29.51K | 24.8K | 22.7K | 21.6K | 28.99K | 7.54K | 4.69K | 1.26K |
Add to Watchlist
Select watchlists to add or remove RNAZ